Cell Medica and Baylor extend partnership for off-the-shelf T Cells
Baylor College of Medicine has extended a partnership to develop off-the-shelf allogeneic cell therapies for Cell Medica.
Baylor College of Medicine has extended a partnership to develop off-the-shelf allogeneic cell therapies for Cell Medica.
Manufacturing quality is key for biosimilar success says Pfenex, as the US FDA continues to increase its regulatory oversight.